Tyblume Kit
Product Images NDC 0642-7471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tyblume (NDC 0642-7471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exeltis Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Levonorgestrel 01)

Figure 1 (Levonorgestrel 01)
The text is a table showing the number of women who experienced a blood clot out of 10,000 women years, categorized by pregnancy status and COC use. The table includes a row for non-COC users and a row for COC users. There is also a row for postpartum women, with a note indicating that the data only covers up to 12 weeks postpartum. The table includes ranges of ages from 10 to 70 years.*
FDA Label Image

Chemical Structure (Levonorgestrel 02)

FDA Label Image

Chemical Structure (Levonorgestrel 03)

FDA Label Image

Image (Levonorgestrel 04)

Image (Levonorgestrel 04)
This text provides information on various birth control methods and their effectiveness in preventing pregnancy. It includes statistics on the number of pregnancies per 100 women using different types of birth control methods over a one-year period. The methods range from hormonal methods like birth control pills, patches, and injections to non-hormonal methods like condoms and diaphragms. It also includes methods like withdrawal and no birth control, which are less effective at preventing pregnancy.*
FDA Label Image

Figure A (Levonorgestrel 05)

FDA Label Image

Figure B (Levonorgestrel 06)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Tyblume 2 is a blister card containing 28 chewable tablets that are dissolved in the mouth. Each blister card has 2 changeable sheets, with each sheet carrying 21 tablets of 1g of Evenylestradiol and 2mg of Diosgenin. The tablets are manufactured by Exeltis and are useful for treating hormonal imbalance. The packaging has batch details, manufacturing, and expiry dates. The text is readable, and the product information is provided in detail.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.